G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.128, Iss.2, 2011-07, pp. : 457-466

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

KiSS1 and its G-protein-coupled receptor GPR54 in cancer development and metastasis

By Cho Sung-Gook

Cancer and Metastasis Reviews, Vol. 31, Iss. 3-4, 2012-12 ,pp. : 585-591

Springer Publishing Company

Access to resources Recommend Favorite

Role of GPR30 in the mechanisms of tamoxifen resistance in breast cancer MCF-7 cells

By Ignatov Atanas

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 87-96

Springer Publishing Company

Access to resources Recommend Favorite

GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer

By Arias-Pulido Hugo

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 51-58

Springer Publishing Company

Access to resources Recommend Favorite

Phosphorylation of estrogen receptor α at serine 118 is correlated with breast cancer resistance to tamoxifen

Oncology Letters, Vol. 6, Iss. 1, 2013-01 ,pp. : 118-124

Spandidos Publications

Access to resources Recommend Favorite

Baicalein suppresses 17-β-estradiol-induced migration, adhesion and invasion of breast cancer cells via the G protein-coupled receptor 30 signaling pathway

Oncology Reports, Vol. 33, Iss. 4, 2015-01 ,pp. : 2077-2085

Spandidos Publications

Access to resources Recommend Favorite